Forest Laboratories Inc.

Forest Laboratories, Inc. develops, manufactures, and sells branded and generic forms of ethical drug products. Its principal products include Lexapro for the treatment of depression in adults and adolescents, and generalized anxiety disorder in adults; Namenda for the treatment of Alzheimer's disease; Bystolic for the treatment of hypertension; and Savella for the management of fibromyalgia.

Ticker:
FRX
Exchange:
NYSE (See More NYSE Companies)
Sector:
Healthcare (See More Healthcare Companies)